Miracor Medical Systems
Develops a PREssure-controlled intermittent coronary sinus occlusion technology for heart patients
Total raised
€17M
€16,772,727
Funding rounds
3
Investors
3
distinct backers
Active since
2011-09
latest 2014-12
Funding by year
EUR raised per yearSignals
High confidenceRaise-next likelihood21
base rate 48% for Series B
- ▼ Dormant (no round in 3+ cohort gaps)
- ▲ Up-round momentum
Exit likelihood16
base rate 12% (2+ rounds)
- ▲ 3 rounds raised
- ▲ 18y since founding
Timing: dormant vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
3 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2015-01-01 | Series B | €4.5M | BioMed Partners,Earlybird Venture Capital | View deal → |
| 2012-02-01 | Grant | €3.2M | — | View deal → |
| 2011-10-01 | Series B | €9.1M | Austria Wirtschaftsservice,Earlybird Venture Capital | View deal → |
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- Roivant Sciences€1.2BSwitzerland · Healthtech
- CMR Surgical€1.2BUK · Healthtech
- Oura Health€779MFinland · Healthtech
- Doctolib€734MFrance · E-commerce